As of mid-February, Dexeus Mujer has taken over the management of the Gynaecology and Obstetrics Department at the Hospital Universitari General de Catalunya (HUGC), located in Sant Cugat del Vallès. Moreover, Dexeus Mujer has added assisted reproductive services to this department.
Gemma Arroyo, a senior embryologist at Dexeus Mujer, has been appointed as the new Coordinator of the Special Interest Group on Embryology of the European Society of Human Reproduction and Embryology (ESHRE).
Dexeus Mujer has incorporated a new technique that will speed up and facilitate smear test analysis. It consists of a digital system that uses “liquid-based cytology” and involves introducing the samples in a liquid medium, which has an immediate preservative action, dissolves lumps, separates the cells…
A team of researchers from Dexeus Mujer, in collaboration with Professor FR Pérez-López of the Faculty of Medicine of the University of Zaragoza, has conducted a study to assess the relationship between endogenous hormonal factors and dominant hand grip strength in postmenopausal women.
Dexeus Mujer has conducted a prospective study to evaluate whether starting ovarian stimulation in the luteal phase (LS) or the follicular phase (FS) of the menstrual cycle offers better reproductive outcomes. The study was conducted in 44 oocyte donors who underwent…
A group of researchers at Dexeus Mujer, led by Dr Raquel Mula, has conducted a prospective study to improve the prediction of foetal growth restriction in a population of pregnant women at high risk of developing early pre-eclampsia…
A group of researchers at Dexeus Mujer, led by biologist Beatriz Carrasco, carried out a retrospective study to determine the sex ratio in the blastocyst stage of human embryos generated by ICSI, in transferred and implanted euploid blastocysts, and, finally, in babies at birth.
Although ICSI has meant a significant advance in the field of reproductive medicine in patients with male infertility problems, there is a certain disparity of opinions in the medical world about its use in other cases of infertility.
The study, led by the biologist Dr Elisabet Clua, head of the Oocyte and Embryo Donation Programme at Dexeus Mujer, was carried out at this centre between April 2017 and August 2018. The sample of women under study were recipients…
Dr Mª Angela Pascual, head of R&D&I at the Gynaecological Diagnostic Imaging Service of Dexeus Mujer, has participated in a large prospective multicentre European study performed in pre- and post-menopausal women in order to describe the ultrasound findings…
In the last two decades, C-section rates have risen from 15 to 25% in the public healthcare system, and from 28 to 38% in the private sector. The causes of this increase are many and, often, unclear. For this reason, Dexeus Mujer has participated in a retrospective study…
A team of researchers at Dexeus Mujer has carried out a study, led by Dr Máximo Izquierdo, which analyses the relationship between bone mineral density (BMD) and breast cancer in postmenopausal women. The study was carried out on a sample of 340…
Carme Pons, a clinical embryologist at Dexeus Mujer and a member of the Embryology Interest Group of the Spanish Association for the Study of Reproductive Biology (ASEBIR), has led a multicentre study promoted by this interest group.
At Dexeus Mujer, two techniques are routinely applied to maintain haemostasis: temporary clipping of both uterine arteries at their origin and of the ovarian vessels at the pelvic infundibulum, and intramyometrial epinephrine injection before performing the hysterectomy.
The variables analyzed were: age, age of onset of menopause, smoking and grip strength, body mass index and adiposity assessed by bioelectrical impedance. Physical activity levels were assessed by means the International Physical Activity Questionnaire.
A total of 1,495 cryotransfer cycles with Preimplantation Genetic Testing (PGT) performed between August 2017 and December 2019 analysed. All patients were between 18 and 40 years old and had previously undergone an ovarian stimulation treatment.
DEXEUS CAMPUS
Gran Vía de Carles III 71-75
08028 Barcelona
campus@dexeus.com
(+34) 93 227 47 09
